Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MAXCYTE, INC. | 230,577 | reported | 13 Aug 2025 | tx 10+408,968 |
| Aldeyra Therapeutics, Inc. | 195,000 | reported | 19 Mar 2026 | tx 36+564,554 |
| NOVAVAX INC | 18,884 | reported | 20 Jun 2025 | tx 43+1,132,530−26,840 |
| IOMAI CORP | 0 | reported | 05 Aug 2008 | tx 9+20,000−56,537 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | PURCHASE | Aldeyra Therapeutics, Inc. | 70,000 | 1.40 USD | |
| 13 Aug 2025 | PURCHASE | MAXCYTE, INC. | 80,000 | 1.39 USD | first after silence |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 18,884 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | NOVAVAX INC | 28,326 | 6.42 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | MAXCYTE, INC. | 29,210 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | MAXCYTE, INC. | 50,790 | 0.00 USD | deriv |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | |
| 12 Jun 2025 | EXERCISE | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 62,728 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 14,476 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 1,689 | 0.00 USD | deriv |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | |
| 12 Jun 2024 | EXERCISE | NOVAVAX INC | 6,670 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 15,630 | 15.86 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | NOVAVAX INC | 10,420 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | MAXCYTE, INC. | 21,367 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | MAXCYTE, INC. | 40,701 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 1,215 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 10,418 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 40,282 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 640 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 21,222 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Aldeyra Therapeutics, Inc. | 5,488 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | MAXCYTE, INC. | 50,000 | 0.00 USD | deriv |
| 10 Jun 2023 | EXERCISE | NOVAVAX INC | 3,100 | — |
6 purchases reported after at least 12 months of silence — most recent on 13 Aug 2025.